FI751186A - - Google Patents
Info
- Publication number
- FI751186A FI751186A FI751186A FI751186A FI751186A FI 751186 A FI751186 A FI 751186A FI 751186 A FI751186 A FI 751186A FI 751186 A FI751186 A FI 751186A FI 751186 A FI751186 A FI 751186A
- Authority
- FI
- Finland
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US462944A US3886170A (en) | 1974-04-22 | 1974-04-22 | 5-(3-)SUBSTITUTED-10,11-DIHYDRO-5H-dibenz{8 b,f{9 azepines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| FI751186A true FI751186A (xx) | 1975-10-23 |
Family
ID=23838322
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI751186A FI751186A (xx) | 1974-04-22 | 1975-04-21 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US3886170A (xx) |
| JP (1) | JPS50148376A (xx) |
| AU (1) | AU8046175A (xx) |
| BE (1) | BE828097A (xx) |
| BR (1) | BR7502134A (xx) |
| DE (1) | DE2515883A1 (xx) |
| DK (1) | DK170775A (xx) |
| ES (1) | ES436793A1 (xx) |
| FI (1) | FI751186A (xx) |
| FR (1) | FR2267787A1 (xx) |
| IL (1) | IL47129A0 (xx) |
| IN (1) | IN142243B (xx) |
| NL (1) | NL7504701A (xx) |
| NO (1) | NO751428L (xx) |
| SE (1) | SE7504415L (xx) |
| ZA (1) | ZA752586B (xx) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY113463A (en) * | 1994-01-04 | 2002-03-30 | Novo Nordisk As | Novel heterocyclic compounds |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3324113A (en) * | 1967-06-06 | Certain oxy derivatives of iminodibenzyl | ||
| US3040031A (en) * | 1962-06-19 | N-heterocyclic compounds | ||
| NL110232C (xx) * | 1958-12-06 | |||
| NL274920A (xx) * | 1961-02-17 | 1900-01-01 | ||
| DE1159954B (de) * | 1961-11-25 | 1963-12-27 | Boehringer & Soehne Gmbh | Verfahren zur Herstellung neuer 10-(Alkoxypiperidinopropyl)-phenthiazine und ihrer Salze |
| US3329683A (en) * | 1963-05-23 | 1967-07-04 | Yoshitomi Pharmaceutical | N((4, 4-substituted piperidino) lower alkyl)iminodibenzyl compounds |
| CH442317A (de) * | 1964-06-26 | 1967-08-31 | Geigy Ag J R | Verfahren zur Herstellung von Azepinderivaten |
| SE349031B (xx) * | 1967-07-03 | 1972-09-18 | Yoshitomi Pharmaceutical | |
| US3668210A (en) * | 1968-02-07 | 1972-06-06 | Yoshitomi Pharmaceutical | 3-chloro dihydrodibenzazepine derivatives |
-
1974
- 1974-04-22 US US462944A patent/US3886170A/en not_active Expired - Lifetime
-
1975
- 1975-04-09 BR BR2715/75A patent/BR7502134A/pt unknown
- 1975-04-11 DE DE19752515883 patent/DE2515883A1/de active Pending
- 1975-04-14 IN IN745/CAL/1975A patent/IN142243B/en unknown
- 1975-04-16 SE SE7504415A patent/SE7504415L/xx unknown
- 1975-04-18 BE BE155532A patent/BE828097A/xx unknown
- 1975-04-21 NL NL7504701A patent/NL7504701A/xx unknown
- 1975-04-21 ES ES436793A patent/ES436793A1/es not_active Expired
- 1975-04-21 DK DK170775A patent/DK170775A/da active IP Right Grant
- 1975-04-21 FI FI751186A patent/FI751186A/fi not_active Application Discontinuation
- 1975-04-21 IL IL47129A patent/IL47129A0/xx unknown
- 1975-04-21 FR FR7512374A patent/FR2267787A1/fr not_active Withdrawn
- 1975-04-21 NO NO751428A patent/NO751428L/no unknown
- 1975-04-22 JP JP50049055A patent/JPS50148376A/ja active Pending
- 1975-04-22 ZA ZA00752586A patent/ZA752586B/xx unknown
- 1975-04-23 AU AU80461/75A patent/AU8046175A/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| SE7504415L (sv) | 1975-10-23 |
| ZA752586B (en) | 1976-04-28 |
| BR7502134A (pt) | 1976-03-09 |
| BE828097A (fr) | 1975-08-18 |
| NO751428L (xx) | 1975-10-23 |
| DK170775A (da) | 1975-10-23 |
| IL47129A0 (en) | 1975-06-25 |
| JPS50148376A (xx) | 1975-11-27 |
| US3886170A (en) | 1975-05-27 |
| AU8046175A (en) | 1976-10-28 |
| ES436793A1 (es) | 1977-01-01 |
| DE2515883A1 (de) | 1975-11-06 |
| FR2267787A1 (xx) | 1975-11-14 |
| IN142243B (xx) | 1977-06-18 |
| NL7504701A (nl) | 1975-10-24 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Application lapsed |
Owner name: A.H. ROBINS COMPANY, INCORPORATED |